Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study

Journal of Antimicrobial Chemotherapy · Published 2026-07-02 · DOI 10.1093/jac/dkag247

Authors (8)

Thomas Drumel, Julie Kimmerlin, Clotilde Allavena, Colin Deschanvres, Eric Billaud, Justine Sourice, Elisabeth Andre-Garnier, François Raffi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Drumel, T., Kimmerlin, J., Allavena, C., et al. (2026). Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag247

Related articles